the result in 2Q18. This decrease was a result of the extraordinary items and also the new investments. Without these items, the Company reported an increase operating result of THB 78 million from the

increased substantially which can outweigh lower visit number. The increase of revenue per visit was the result of more surgeries operated particularly heart surgeries and minimal invasive surgeries. All

high at 114.02 KBD. Marketing Business was able to increase market share and maintain its 2nd position in the market. Power Plant Business realized additional profit from Solar and Wind Power Plants. As

Option Program : ESOP) without having obtained an approval from the SEC Office. SEC Act S.33 Settlement Committee Meeting No. 8/2023 Settlement Committee Order No. 70/2023 Dated 21/09/2023

entitled for subscription of new ordinary shares (Record Date) and Subscription period To: The President of the Stock Exchange of Thailand Enclosure: 1. No. For. 19/2018 Capital Increase, Waiver from

selling price of hot-rolled coil for the year in 2017 increase around 18.54% comparing with last year together with the well manage production of the Company, the Company can generate cash margin by Baht

12,391 10,868 Average selling price of hot-rolled coil for the year in 2017 increase around 18.54% comparing with last year together with the well manage production of the Company, the Company can generate

31 st March, 2018 which was reviewed by authorized Auditor with the details as follows: The total revenues of the Company and its Subsidiaries in the Quarter 1/2018 was 165.55 million Baht, an increase

performance are as follows: Sales Revenue Sales revenue for Q2/2017 of 269.33 million baht shows an increase of 99.98 million baht or 59.04% y-o-y. Cost of sales of 172.40 million baht shows an increase of

to the same period of previous year which a net loss of Baht 5.43 million, the loss increase Baht 7.45 million or increase by 137.09% , the main reasons are as follow 1. Revenue from sale , Other